Clinical guidelines for PTH analogs

Clinical guidelines for PTH (parathyroid hormone) analogs recommend their use primarily for treating people with severe osteoporosis caused by hypoparathyroidism. They are prescribed when calcium levels are hard to control with standard therapy, and there’s a risk of fractures. Treatment involves careful monitoring of calcium and vitamin D levels to avoid side effects like high calcium levels. PTH analogs are generally used for a limited time and under specialized medical supervision. The goal is to improve bone strength and reduce fracture risk while maintaining safe calcium balance.